-
An L, Liu R, Tang W, Wu JG, Chen X, 2014: Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs[J]. Antiviral Res, 109, 54-63. doi: 10.1016/j.antiviral.2014.06.007
-
Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization Consultation on Human Influenza AH (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353: 1374-1385
-
Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL, 2018: Host immune response to influenza A virus infection[J]. Front Immunol, 9, 320-. doi: 10.3389/fimmu.2018.00320
-
Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z, 2011: Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection[J]. Am J Pathol, 179, 2963-2976. doi: 10.1016/j.ajpath.2011.09.003
-
Davidson S, 2018: Treating influenza infection, from now and into the future[J]. Front Immunol, 9, 1946-. doi: 10.3389/fimmu.2018.01946
-
de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha Do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J, 2006: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia[J]. Nat Med, 12, 1203-1207. doi: 10.1038/nm1477
-
Deng R, Lu M, Korteweg C, Gao Z, McNutt MA, Ye J, Zhang T, Gu J, 2008: Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients[J]. J Pathol, 216, 328-336. doi: 10.1002/path.2417
-
Enoki Y, Ishima Y, Tanaka R, Sato K, Kimachi K, Shirai T, Watanabe H, Chuang VT, Fujiwara Y, Takeya M, Otagiri M, Maruyama T, 2015: Pleiotropic effects of levofloxacin, fluoroquinolone antibiotics, against influenza virus-induced lung injury[J]. PLoS ONE, 10, e0130248-. doi: 10.1371/journal.pone.0130248
-
Florence JM, Krupa A, Booshehri LM, Davis SA, Matthay MA, Kurdowska AK, 2018: Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 315, L52-L58. doi: 10.1152/ajplung.00047.2018
-
Gao R, Bhatnagar J, Blau DM, Greer P, Rollin DC, Denison AM, Deleon-Carnes M, Shieh WJ, Sambhara S, Tumpey TM, Patel M, Liu L, Paddock C, Drew C, Shu Y, Katz JM, Zaki SR, 2013: Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis[J]. Am J Pathol, 183, 1258-1268. doi: 10.1016/j.ajpath.2013.06.023
-
Garcia A, Serrano A, Abril E, Jimenez P, Real LM, Canton J, Garrido F, Ruiz-Cabello F, 1999: Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression[J]. Exp Hematol, 27, 353-364. doi: 10.1016/S0301-472X(98)00038-1
-
Genin M, Clement F, Fattaccioli A, Raes M, Michiels C, 2015: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide[J]. BMC Cancer, 15, 577-. doi: 10.1186/s12885-015-1546-9
-
Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, McAuliffe B, Minassian BF, Shi SH, Zhu SR, Zhai WX, Pendri A, Li G, Poss MA, Edavettal S, McDonnell PA, Lewis HA, Maskos K, Mortl M, Kiefersauer R, Steinbacher S, Baldwin ET, Metzler W, Bryson J, Healy MD, Philip T, Zoeckler M, Schartman R, Sinz M, Leyva-Grado VH, Hoffmann HH, Langley DR, Meanwell NA, Krystal M, 2011: Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers[J]. Proc Natl Acad Sci USA, 108, 15366-15371. doi: 10.1073/pnas.1107906108
-
Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C, 2001: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression[J]. Methods, 25, 386-401. doi: 10.1006/meth.2001.1261
-
Hay AJ, Gregory V, Douglas AR, Lin YP, 2001: The evolution of human influenza viruses[J]. Philos Trans R Soc Lond B Biol Sci, 356, 1861-1870. doi: 10.1098/rstb.2001.0999
-
Hoffmann HH, Palese P, Shaw ML, 2008: Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity[J]. Antiviral Res, 80, 124-134. doi: 10.1016/j.antiviral.2008.05.008
-
Hrincius ER, Liedmann S, Finkelstein D, Vogel P, Gansebom S, Samarasinghe AE, You D, Cormier SA, McCullers JA, 2015: Acute lung injury results from innate sensing of viruses by an ER stress pathway[J]. Cell Rep, 11, 1591-1603. doi: 10.1016/j.celrep.2015.05.012
-
Hui DS, Lee N, 2013: Adjunctive therapies and immunomodulating agents for severe influenza[J]. Influenza Other Respir Viruses, 7, 52-59.
-
Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y, 2013: CXCL10-CXCR19 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin[J]. Am J Respir Crit Care Med, 187, 65-77. doi: 10.1164/rccm.201203-0508OC
-
Iwasaki A, Pillai PS, 2014: Innate immunity to influenza virus infection[J]. Nat Rev Immunol, 14, 315-328. doi: 10.1038/nri3665
-
Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B, 2013: PAR1 contributes to influenza A virus pathogenicity in mice[J]. J Clin Invest, 123, 206-214. doi: 10.1172/JCI61667
-
Kozak W, Zheng H, Conn CA, Soszynski D, Ploeg LHVD, Kluger MJ, 1995: Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice[J]. Am J Physiol Regul Integr Comp Physiol, 269, R969-R977. doi: 10.1152/ajpregu.1995.269.5.R969
-
Lauder SN, Taylor PR, Clark SR, Evans RL, Hindley JP, Smart K, Leach H, Kidd EJ, Broadley KJ, Jones SA, Wise MP, Godkin AJ, O'Donnell V, Gallimore AM, 2011: Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity[J]. Thorax, 66, 368-374. doi: 10.1136/thx.2010.150318
-
Liu Z, Guo Z, Wang G, Zhang D, He H, Li G, Liu Y, Higgins D, Walsh A, Shanahan-Prendergast L, Lu J, 2009: Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice[J]. Eur J Pharm Sci, 38, 215-223. doi: 10.1016/j.ejps.2009.07.004
-
Liu Q, Liu DY, Yang ZQ, 2013: Characteristics of human infection with avian influenza viruses and development of new antiviral agents[J]. Acta Pharmacol Sin, 34, 1257-1269. doi: 10.1038/aps.2013.121
-
Liu Q, Zhou YH, Yang ZQ, 2016: The cytokine storm of severe influenza and development of immunomodulatory therapy[J]. Cell Mol Immunol, 13, 3-10. doi: 10.1038/cmi.2015.74
-
Mehrbod P, Omar AR, Hair-Bejo M, Haghani A, Ideris A, 2014: Mechanisms of action and efficacy of statins against influenza[J]. Biomed Res Int, , 872370-.
-
Millius A, Weiner OD, 2009: Chemotaxis in neutrophil-like HL-60 cells[J]. Methods Mol Biol, 571, 167-177.
-
Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P, 2008: Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses[J]. PLoS Pathog, 4, e1000151-. doi: 10.1371/journal.ppat.1000151
-
Moseley CE, Webster RG, Aldridge JR, 2010: Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice[J]. Influenza Other Respir Viruses, 4, 307-311. doi: 10.1111/j.1750-2659.2010.00155.x
-
Pulendran B, Maddur MS, 2015: Innate immune sensing and response to influenza[J]. Curr Top Microbiol Immunol, 386, 23-71.
-
Ramos I, Fernandez-Sesma A, 2015: Modulating the innate immune response to influenza A virus: potential therapeutic use of anti-inflammatory drugs[J]. Front Immunol, 6, 361-.
-
Reed LJ, Muench H, 1938: A simple method of estimating fifty per cent endpoints[J]. Am J Epidemiol, 27, 493-497. doi: 10.1093/oxfordjournals.aje.a118408
-
Sato K, Suga M, Akaike T, Fujii S, Muranaka H, Doi T, Maeda H, Ando M, 1998: Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice[J]. Am J Respir Crit Care Med, 157, 853-857. doi: 10.1164/ajrccm.157.3.9703098
-
Sharma G, Champalal Sharma D, Hwei Fen L, Pathak M, Bethur N, Pendharkar V, Peiris M, Altmeyer R, 2013: Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor[J]. Emerg Microbes Infect, 2, e54-.
-
Short KR, Kroeze EJBV, Fouchier RAM, Kuiken T, 2014: Pathogenesis of influenza-induced acute respiratory distress syndrome[J]. Lancet Infect Dis, 14, 57-69. doi: 10.1016/S1473-3099(13)70286-X
-
Smee DF, Bailey KW, Wong MH, O'Keefe BR, Gustafson KR, Mishin VP, Gubareva LV, 2008: Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N[J]. Antiviral Res, 80, 266-271. doi: 10.1016/j.antiviral.2008.06.003
-
Taubenberger JK, Morens DM, 2006: 1918 influenza: the mother of all pandemics[J]. Emerg Infect Dis, 12, 15-22. doi: 10.3201/eid1209.05-0979
-
Tavares LP, Teixeira MM, Garcia CC, 2017: The inflammatory response triggered by Influenza virus: a two edged sword[J]. Inflamm Res, 66, 283-302. doi: 10.1007/s00011-016-0996-0
-
Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H, 2011: Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection[J]. Cell, 146, 980-991. doi: 10.1016/j.cell.2011.08.015
-
Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG, 2012: Into the eye of the cytokine storm[J]. Microbiol Mol Biol Rev, 76, 16-32. doi: 10.1128/MMBR.05015-11
-
To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY, 2010: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection[J]. Clin Infect Dis, 50, 850-859. doi: 10.1086/650581
-
Tsai AW, McNeil CF, Leeman JR, Bennett HB, Nti-Addae K, Huang C, Germann UA, Byrn RA, Berlioz-Seux F, Rijnbrand R, Clark MP, Charifson PS, Jones SM, 2015: Novel ranking system for identifying efficacious anti-influenza virus PB2 inhibitors[J]. Antimicrob Agents Chemother, 59, 6007-6016. doi: 10.1128/AAC.00781-15
-
Wang W, Yang P, Zhong Y, Zhao Z, Xing L, Zhao Y, Zou Z, Zhang Y, Li C, Li T, Wang C, Wang Z, Yu X, Cao B, Gao X, Penninger JM, Wang X, Jiang C, 2013: Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury[J]. Cell Res, 23, 577-580. doi: 10.1038/cr.2013.25
-
Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR, 2004: Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice[J]. J Leukoc Biol, 76, 886-895. doi: 10.1189/jlb.1203644
-
WHO (2018) Influenza (seasonal). World Health Organization. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 26 Apr 2019
-
Zhang JH, Chung TDY, Oldenburg KR, 1999: A simple statistical parameter for use in evaluation and validation of high throughput screening assays[J]. J Biomol Screen, 4, 67-73. doi: 10.1177/108705719900400206
-
Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, Chen HL, Wong SS, Lau SK, Woo PC, Chan KH, Jin DY, Yuen KY, 2008: Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus[J]. Proc Natl Acad Sci USA, 105, 8091-8096. doi: 10.1073/pnas.0711942105